An analysis of the 2025 AHA/ACC hypertension guidelines found that under the new guidelines, about 11% of adults ages 65 to 79 with stage I hypertension would no longer qualify for blood pressure medication, a major shift from previous rules that recommended treatment for all adults in this age range. The newly exempt group is made up of generally healthy, lower-risk older adults whose predicted 10-year cardiovascular risk falls below the new treatment threshold. The analysis is published in the Annals of Internal Medicine.
This article was originally published on MedicalXpress.com
